Standard

Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. / Beaulieu, JM; Del'guidice, T; Sotnikova, TD; Lemasson, M; Gainetdinov, RR.

In: Frontiers in Molecular Neuroscience, 2011.

Research output: Contribution to journalLiterature review

Harvard

Beaulieu, JM, Del'guidice, T, Sotnikova, TD, Lemasson, M & Gainetdinov, RR 2011, 'Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors.', Frontiers in Molecular Neuroscience.

APA

Beaulieu, JM., Del'guidice, T., Sotnikova, TD., Lemasson, M., & Gainetdinov, RR. (2011). Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. Frontiers in Molecular Neuroscience.

Vancouver

Beaulieu JM, Del'guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR. Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. Frontiers in Molecular Neuroscience. 2011.

Author

Beaulieu, JM ; Del'guidice, T ; Sotnikova, TD ; Lemasson, M ; Gainetdinov, RR. / Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. In: Frontiers in Molecular Neuroscience. 2011.

BibTeX

@article{af372592b91b4410a639fbcebdc2f664,
title = "Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors.",
abstract = "Brain dopamine receptors have been preferred targets for numerous pharmacological compounds developed for the treatment of various neuropsychiatric disorders. Recent discovery that D2 dopamine receptors, in addition to cAMP pathways, can engage also in Akt/GSK3 signaling cascade provided a new framework to understand intracellular signaling mechanisms involved in dopamine-related behaviors and pathologies. Here we review a recent progress in understanding the role of Akt, GSK3, and related signaling molecules in dopamine receptor signaling and functions. Particularly, we focus on the molecular mechanisms involved, interacting partners, role of these signaling events in the action of antipsychotics, psychostimulants, and antidepressants as well as involvement in pathophysiology of schizophrenia, bipolar disorder, and Parkinson's disease. Further understanding of the role of Akt/GSK3 signaling in dopamine receptor functions could provide novel targets for pharmacological interventions in dopamine-related disord",
keywords = "Akt, G protein coupled receptor, arrestin, catecholamines, dopamine, glycogen synthase kinase 3, protein kinase B, receptor tyrosine kinase",
author = "JM Beaulieu and T Del'guidice and TD Sotnikova and M Lemasson and RR. Gainetdinov",
year = "2011",
language = "не определен",
journal = "Frontiers in Molecular Neuroscience",
issn = "1662-5099",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors.

AU - Beaulieu, JM

AU - Del'guidice, T

AU - Sotnikova, TD

AU - Lemasson, M

AU - Gainetdinov, RR.

PY - 2011

Y1 - 2011

N2 - Brain dopamine receptors have been preferred targets for numerous pharmacological compounds developed for the treatment of various neuropsychiatric disorders. Recent discovery that D2 dopamine receptors, in addition to cAMP pathways, can engage also in Akt/GSK3 signaling cascade provided a new framework to understand intracellular signaling mechanisms involved in dopamine-related behaviors and pathologies. Here we review a recent progress in understanding the role of Akt, GSK3, and related signaling molecules in dopamine receptor signaling and functions. Particularly, we focus on the molecular mechanisms involved, interacting partners, role of these signaling events in the action of antipsychotics, psychostimulants, and antidepressants as well as involvement in pathophysiology of schizophrenia, bipolar disorder, and Parkinson's disease. Further understanding of the role of Akt/GSK3 signaling in dopamine receptor functions could provide novel targets for pharmacological interventions in dopamine-related disord

AB - Brain dopamine receptors have been preferred targets for numerous pharmacological compounds developed for the treatment of various neuropsychiatric disorders. Recent discovery that D2 dopamine receptors, in addition to cAMP pathways, can engage also in Akt/GSK3 signaling cascade provided a new framework to understand intracellular signaling mechanisms involved in dopamine-related behaviors and pathologies. Here we review a recent progress in understanding the role of Akt, GSK3, and related signaling molecules in dopamine receptor signaling and functions. Particularly, we focus on the molecular mechanisms involved, interacting partners, role of these signaling events in the action of antipsychotics, psychostimulants, and antidepressants as well as involvement in pathophysiology of schizophrenia, bipolar disorder, and Parkinson's disease. Further understanding of the role of Akt/GSK3 signaling in dopamine receptor functions could provide novel targets for pharmacological interventions in dopamine-related disord

KW - Akt

KW - G protein coupled receptor

KW - arrestin

KW - catecholamines

KW - dopamine

KW - glycogen synthase kinase 3

KW - protein kinase B

KW - receptor tyrosine kinase

M3 - Обзор литературы

JO - Frontiers in Molecular Neuroscience

JF - Frontiers in Molecular Neuroscience

SN - 1662-5099

ER -

ID: 5573459